Cancer Detection Rates of Systematic and Targeted Prostate Biopsies after Biparametric MRI

Table 3

Whole group pathology outcomes of systematic biopsy and targeted biopsy.

Targeted biopsy	Systematic biopsy			Total
	No cancer	≤2 cores Gleason 6	≥3 cores Gleason 6 or ≥Gleason 7
Not performed	15	6	3	24
No cancer	22	3	4	29
≤2 cores Gleason 6	2	4	4	10
≥3 cores Gleason 6 or ≥Gleason 7	3	0	16	19
Total	42	13	27	82

Pathology outcomes per patient for systematic biopsy and targeted MR/US fusion biopsy. The numbers in bold indicate patients with a pathology upgrade of clinical importance with systematic biopsy. The numbers in italics indicate patients with a pathology upgrade of clinical importance with targeted biopsy.